552 related articles for article (PubMed ID: 30580380)
41. Primary Central Nervous System Natural Killer Cell Lymphoma in a Chinese Woman with Atypical (11)C-Choline Positron Emission Tomography and Magnetic Resonance Spectrometry Findings.
Li LF; Taw BB; Pu JK; Hwang GY; Lui WM; Leung GK
World Neurosurg; 2015 Oct; 84(4):1176.e5-9. PubMed ID: 26142813
[TBL] [Abstract][Full Text] [Related]
42. Pretreatment findings on magnetic resonance imaging in primary central nervous system lymphoma may predict overall survival duration.
Huntoon K; Makary MS; Shah VS; Aquino A; Pandya V; Giglio P; Slone HW; Elder JB
Neuroradiol J; 2023 Aug; 36(4):479-485. PubMed ID: 36715098
[TBL] [Abstract][Full Text] [Related]
43. Primary central nervous system lymphoma in AIDS: a wider spectrum of CT and MRI findings.
Thurnher MM; Rieger A; Kleibl-Popov C; Settinek U; Henk C; Haberler C; Schindler E
Neuroradiology; 2001 Jan; 43(1):29-35. PubMed ID: 11214644
[TBL] [Abstract][Full Text] [Related]
44. Primary central nervous system lymphoma with lymphomatosis cerebri in an immunocompetent child: MRI and 18F-FDG PET-CT findings.
Jain TK; Sharma P; Suman SK; Faizi NA; Bal C; Kumar R
Rev Esp Med Nucl Imagen Mol; 2013; 32(6):394-6. PubMed ID: 23743243
[TBL] [Abstract][Full Text] [Related]
45. Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients.
Küker W; Nägele T; Korfel A; Heckl S; Thiel E; Bamberg M; Weller M; Herrlinger U
J Neurooncol; 2005 Apr; 72(2):169-77. PubMed ID: 15925998
[TBL] [Abstract][Full Text] [Related]
46. Neuroimaging and clinicopathological differences between tumefactive demyelinating lesions and sentinel lesions of primary central nervous system lymphoma.
Sun C; Han J; Lin Y; Qi X; Li C; Liu J; Qiu F
Front Immunol; 2022; 13():986473. PubMed ID: 36059526
[TBL] [Abstract][Full Text] [Related]
47. Pretreatment dynamic contrast-enhanced MRI biomarkers correlate with progression-free survival in primary central nervous system lymphoma.
Hatzoglou V; Oh JH; Buck O; Lin X; Lee M; Shukla-Dave A; Young RJ; Peck KK; Vachha B; Holodny AI; Grommes C
J Neurooncol; 2018 Nov; 140(2):351-358. PubMed ID: 30073640
[TBL] [Abstract][Full Text] [Related]
48. (11)C-methionine PET/CT and MRI of primary central nervous system diffuse large B-cell lymphoma before and after high-dose methotrexate.
Jang SJ; Lee KH; Lee JY; Choi JY; Kim BT; Kim SJ; Kim WS
Clin Nucl Med; 2012 Oct; 37(10):e241-4. PubMed ID: 22955084
[TBL] [Abstract][Full Text] [Related]
49. New MR perfusion features in primary central nervous system lymphomas: pattern and prognostic impact.
Blasel S; Vorwerk R; Kiyose M; Mittelbronn M; Brunnberg U; Ackermann H; Voss M; Harter PN; Hattingen E
J Neurol; 2018 Mar; 265(3):647-658. PubMed ID: 29383512
[TBL] [Abstract][Full Text] [Related]
50. [Primary lymphoma of the central nervous system in immunocompetent patients: neuroimaging features].
Sobrido-Sampedro C; Corroto JD; Arias-González M; Corroto-Murúa J; Pumar JM
Rev Neurol; 2012 Oct; 55(8):462-8. PubMed ID: 23055427
[TBL] [Abstract][Full Text] [Related]
51. Low ADC in CNS Lymphoma.
Pyatigorskaya N; Galanaud D; Dormont D; Soussain C; Kas A
Clin Nucl Med; 2020 Jul; 45(7):545-546. PubMed ID: 32404710
[TBL] [Abstract][Full Text] [Related]
52. Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG).
Barajas RF; Politi LS; Anzalone N; Schöder H; Fox CP; Boxerman JL; Kaufmann TJ; Quarles CC; Ellingson BM; Auer D; Andronesi OC; Ferreri AJM; Mrugala MM; Grommes C; Neuwelt EA; Ambady P; Rubenstein JL; Illerhaus G; Nagane M; Batchelor TT; Hu LS
Neuro Oncol; 2021 Jul; 23(7):1056-1071. PubMed ID: 33560416
[TBL] [Abstract][Full Text] [Related]
53. Imaging of primary central nervous system lymphoma.
Tang YZ; Booth TC; Bhogal P; Malhotra A; Wilhelm T
Clin Radiol; 2011 Aug; 66(8):768-77. PubMed ID: 21513925
[TBL] [Abstract][Full Text] [Related]
54. Different imaging patterns of PCNSL and IVL: a case report.
Jeon SH; Kang MK; Lee SJ; Shin BS; Kang HG
BMC Neurol; 2019 Dec; 19(1):311. PubMed ID: 31795989
[TBL] [Abstract][Full Text] [Related]
55. Radiomics features to distinguish glioblastoma from primary central nervous system lymphoma on multi-parametric MRI.
Kim Y; Cho HH; Kim ST; Park H; Nam D; Kong DS
Neuroradiology; 2018 Dec; 60(12):1297-1305. PubMed ID: 30232517
[TBL] [Abstract][Full Text] [Related]
56. Quantitative and Visual Characteristics of Primary Central Nervous System Lymphoma on
Liu D; Kong Z; Wang Y; Chen W; Wang Y; Chen W; Liu L; Dang Y; Ma W; Wang Y; Cheng X
Interdiscip Sci; 2019 Jun; 11(2):300-306. PubMed ID: 31264053
[TBL] [Abstract][Full Text] [Related]
57. Utility of post-therapy brain surveillance imaging in the detection of primary central nervous system lymphoma relapse.
Fossard G; Ferlay C; Nicolas-Virelizier E; Rey P; Ducray F; Jouanneau E; Faurie P; Belhabri A; Sunyack MP; Chassagne-Clément C; Thiesse P; Sebban C; Biron P; Blay JY; Ghesquières H
Eur J Cancer; 2017 Feb; 72():12-19. PubMed ID: 28012348
[TBL] [Abstract][Full Text] [Related]
58. Usefulness of carbon-11-labeled methionine positron-emission tomography for assessing the treatment response of primary central nervous system lymphoma.
Miyakita Y; Ohno M; Takahashi M; Kurihara H; Katai H; Narita Y
Jpn J Clin Oncol; 2020 May; 50(5):512-518. PubMed ID: 32129443
[TBL] [Abstract][Full Text] [Related]
59. [Imaging features of primary bone lymphoma and its histopathology].
Li SL; Zhang XL; Han HX; Chen B
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Feb; 27(2):201-4. PubMed ID: 17355937
[TBL] [Abstract][Full Text] [Related]
60. Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry.
Krogh-Jensen M; D'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
Leuk Lymphoma; 1995 Oct; 19(3-4):223-33. PubMed ID: 8535213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]